<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02371382</url>
  </required_header>
  <id_info>
    <org_study_id>ORTHO.CR.H41</org_study_id>
    <nct_id>NCT02371382</nct_id>
  </id_info>
  <brief_title>Multicentre Prospective Study to Evaluate Long-term Clinical Outcomes of the Sirius Cemented Femoral Stem</brief_title>
  <acronym>Sirius</acronym>
  <official_title>Multicentre Prospective Study to Evaluate Long-term Clinical Outcomes of the Sirius Cemented Femoral Stem</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this multicentre, prospective study is:

        -  Document the Clinical and Radiographic performance of the stem at 3 months, 1 year, 3
           years, 5 years, 7 and 10 years.

        -  Report Safety and Survivorship up to 10 years F/up.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study intends to evaluate the safety and performance of the Sirus cemented hip stem in
      terms of function improvement postoperatively, stability and fixation of femoral stem and
      survivorship.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">March 2025</completion_date>
  <primary_completion_date type="Anticipated">March 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Harris Hip Score from Baseline to 1 Year post-surgery</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Harris Hip Score and Oxford Hip Score at 1,3,5, 7 and 10 year postop</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Arthroplasty, Replacement, Hip</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Arthroplasty hip</intervention_name>
    <description>Hip replacement</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        minimum age: 18 maximum age: gender: both
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Selection of subjects for this evaluation should be in accordance with the indications of
        Sirus stem:

          1. Non-inflammatory degenerative joint disease including osteoarthritis and avascular
             necrosis.

          2. Rheumatoid arthritis

          3. Correction of functional deformity

          4. Treatment of non-union, femoral neck fracture and trochanteric fractures of the
             proximal femur with head involvement, unmanageable using other techniques.

          5. Revision procedures where other treatments or devices have failed. The Sirius Femoral
             Hip Stem is intended for cemented use only and may be used in partial and total hip
             arthroplasties

        Exclusion Criteria:

          -  Absolute contraindications include:

        infection, sepsis, osteomyelitis

        Additional contraindications include:

          -  Uncooperative patient or patient with neurologic disorders who are incapable of
             following directions,

          -  Osteoporosis,

          -  Metabolic disorders which may impair bone formation

          -  Osteomalacia

          -  Distant foci of infections which may spread to the implant site

          -  Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram

          -  Vascular insufficiency, muscular atrophy or neuromuscular disease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alun John</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Wales</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas Kristen Poulsen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lillebaelt Hospital Vejle, Denmark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vera M. Weilburg, DVM</last_name>
    <phone>+4917612468385</phone>
    <email>vera.weilburg@zimmerbiomet.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aida Stamm</last_name>
    <phone>+41 58 854 82 15 Direct</phone>
    <email>aida.stamm@zimmerbiomet.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital of Wales, Llandough Hospital</name>
      <address>
        <city>Penarth</city>
        <state>Wales</state>
        <zip>CF64 2XX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alun John, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Claire Nott</last_name>
      <phone>02920 716689</phone>
      <email>Claire.Nott@wales.nhs.uk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 19, 2015</study_first_submitted>
  <study_first_submitted_qc>February 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2015</study_first_posted>
  <last_update_submitted>March 16, 2017</last_update_submitted>
  <last_update_submitted_qc>March 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

